Position in MRK
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$14,758,225
+$588,063 QoQ
Shares Held
114,850
-2.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#605
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HENNESSY ADVISORS INC holds $74,827,284 across 8 Drug Manufacturers - General names. MRK ranks #1 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
114,850 | $14,758,225 | |
| 2 | JNJ |
Johnson & Johnson
|
49,300 | $12,520,721 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
85,199 | $10,764,041 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
163,850 | $9,441,037 | |
| 5 | PFE |
Pfizer Inc
|
296,113 | $7,130,401 | |
| 6 | AMGN |
Amgen Inc
|
19,120 | $6,923,734 | |
| 7 | ABBV |
AbbVie Inc.
|
27,300 | $6,869,772 | |
| 8 | GSK |
GSK plc
|
122,460 | $6,419,353 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,758,225 | 114,850 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $14,170,162 | 117,800 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $12,825,931 | 121,850 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $10,516,429 | 125,300 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $9,934,580 | 125,500 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $11,098,824 | 123,650 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $6,461,226 | 64,950 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,331,642 | 46,950 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $5,348,160 | 43,200 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $5,818,995 | 44,100 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $5,004,018 | 45,900 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $4,993,075 | 48,500 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $5,711,805 | 49,500 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $5,564,197 | 52,300 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $10,518,060 | 94,800 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $10,601,372 | 123,100 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $11,605,941 | 127,300 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,695,217 | 130,350 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $11,691,432 | 152,550 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $11,367,898 | 151,350 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $11,389,416 | 146,450 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $11,008,457 | 142,800 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $8,548,096 | 104,500 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $7,299,603 | 88,000 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $6,944,237 | 89,800 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $7,163,111 | 93,100 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||